InvestorsHub Logo

locksflooring

01/02/10 7:08 AM

#16139 RE: longhorn2745 #16130

Obama Uses Stem Cells All Press Releases for January 2, 2010



Rare Swiss Apple Stem Cells Emerge as Top Anti Aging Skin Care Ingredient for 2010
The Swiss Apple (Uttwiler Spätlauber), is a nearly extinct variety found only in Switzerland. When the unpicked apples or tree bark is punctured, Swiss Apple trees have the ability to heal themselves. Once picked, Swiss Apples last months longer than other varieties. Greensations® brand skin care products has launched a new anti-aging formula using the power of Swiss Apple stem cells in their new ThermaSkin line. By combining the rare fruit extract with Capsaicin and Caffeine, Greensations has come up with a solid balm that protects the delicate stem cells from degradation which significantly decreases manufacturing costs.

Schenectady, NY (PRWEB) January 2, 2010 -- Greensations® brand skin care products has launched a new anti-aging formula using the power of Swiss Apple stem cells in their new ThermaSkin line. By combining the rare fruit extract with Capsaicin and Caffeine, Greensations has come up with a solid balm that protects the delicate stem cells from degradation which significantly decreases manufacturing costs.


ThermaSkin Skin Repair SticksThe Swiss Apple (Uttwiler Spätlauber), is a nearly extinct variety found only in Switzerland. When the unpicked apples or tree bark is punctured, Swiss Apple trees have the ability to heal themselves. Once picked, Swiss Apples last months longer than other varieties. In 2008, Mibelle Biochemistry of Switzerland found the key to this rare apples' longevity to be its unusually resilient stem cells, and they investigated whether this miracle component could be harnessed to slow the aging process in human skin. Using a special process, Mibelle developed a Swiss Apple skin care ingredient called PhytoCellTec®. Their first clinical study showed Swiss Apple stem cells provide powerful anti aging benefits by nourishing and stimulating regeneration of human skin. In a second study using 20 volunteers, the scientists found that line depth was reduced by 15% in wrinkles when used twice daily.


Swiss Apple stem cells are gaining a reputation as the next big anti-aging skin care ingredient for 2010.
This revolutionary anti-aging discovery has opened up a new market for wrinkle creams and serums using Swiss Apple stem cells, but these products cost from $100 up to $1,500 for a fraction of an ounce. So throughout 2009, Swiss Apple stem cells have mainly been used by the rich and famous due to their high cost. Vogue magazine recently reported First Lady, Michelle Obama uses a $300 cream containing the stem cells to diminish her wrinkles. Unfortunately most people cannot afford to spend hundreds of dollars on an anti-aging product, but now there’s an option anyone can afford for less than twenty dollars.

“We developed a way to deliver Swiss Apple stem cells without the inflated cost, by combining them with capsaicin and caffeine in a beeswax balm. The capsaicin and caffeine act as carriers to create super permeability, allowing small doses of stem cells to penetrate skin without evaporating. We use a base of olive oil, grapeseed oil and beeswax, as well as arnica and goldenseal. Then we add the stem cells during the cooling process so they instantly bind with the capsaicin and caffeine to create a solid stick that can be applied as a roll-on. Once the liquid formula becomes solid, the stem cells are suspended in an infusion of natural beeswax. In creams and serums, most stem cells are destroyed by exposure to air, but when formulated in a solid state the cells are protected,” says Niles Porter, Director of Sales for Greensations.

When the fruit stem cells are added to traditional creams and serums, the formulation requires extra amounts to make up for natural degradation but in a solid form, much smaller amounts can be delivered directly to the skin. The result is a solid stick that contains active amounts of Swiss Apple stem cells at a much lower cost than traditional serums and creams. According to the manufacturer, the capsaicin and caffeine work together to promote fast topical absorption by increasing topical blood flow and permeability. Both ingredients also reduce wrinkles and lines on their own while tightening and conditioning skin. When combined with Swiss Apple stem cells, this caffeinated capsaicin formula goes beyond other anti-aging products to provide fast and lasting results without added preservatives or chemicals.

How It Works:
Capsaicin, the active heat component in hot peppers increases topical blood flow and reduces inflammation to tighten skin and promote fast healing. Caffeine is a proven carrier that delivers a nearly 50% absorption rate - far beyond other known topical ingredients. Topical application of caffeine has also been proven to protect and repair human skin cells from UV damage. The makers of Greensations have applied for patents using capsaicin and caffeine to increase topical absorption in a variety of natural skin care products. Their new ThermaSkin™ Skin Repair Sticks are the latest product to use their new innovation with the added touch of Swiss Apple stem cells.

“Our skin repair sticks can be used anytime just like lip balms or similar products. You can use them on wrinkles, crows feet, bags, chapped skin and even chapped lips. They can be carried in your pocket or purse and can be stored at any temperature. You can also carry them while traveling on airplanes where most liquids and creams are presently banned. Best of all, you don’t have to use your hands to apply our formula. Just use the skin stick as you would a roll-on,” Porter adds.

To learn more visit the official Greensations website. Complimentary samples are available for qualified media and medical personnel upon request.

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1TcXVhLUxvdmUtQ3Jhcy1QaWdnLVBpZ2ctWmVybw==



locksflooring

01/02/10 7:12 AM

#16140 RE: longhorn2745 #16130

Stem cells pep up pooch
More than $7,000 later, 11-year-old German shepherd gets her mojo back
By Jim Gibson, Times Colonist

Sandy Draibye plays with her horse Kinney and German shepherd Micki, who received stem cell injections in hopes it would help her joint problems. Lawyer Sandy Draibye barely paused before calling her veterinarian on hearing about a new -- albeit costly -- stem cell therapy. The therapy sounded like the solution to the decreasing mobility plaguing her then 10-year-old German shepherd Micki.

Micki's veterinarian, Amanda Booth of Sooke's Saseenos Veterinary Services, wasn't surprised by Draibye's call. She describes her Vancouver client as very proactive when it comes to her dog's quality of life.

"This is her kid," Booth says.

Booth didn't instantly agree to the procedure, which involves harvesting stem cells, which are present in most multicellular organisms and possess the ability to renew themselves in an injured area. She was more cautious than her "gung-ho" client about a procedure only just available in Canada.

The procedure began with Booth harvesting fat cells from Micki's thigh and dispatching them to the California lab where the regenerative stem cells are isolated. Two days later, the stem cells came back for injection.

Over the years, Micki developed arthritic joint problems in three legs, and had one ligament operation. The dog was in need of a second ligament operation on the other hind leg.

The aging dog relied heavily on daily anti-inflammatory medication, but their long-term use worried Draibye.

At times, Micki also wore a leg brace.

"If the other three legs had been in good shape, I would have held off on the stem cell surgery," Booth says.

But basically, Micki didn't have a good leg left to stand on.

Vet-Stem, the California company with the rights to the procedure, touts it as a breakthrough for the treatment of arthritis, fractures, tendon and ligament injuries in dogs. By mid-summer more than 1,700 dogs in the U.S. had undergone the therapy since early last year, according to a company representative. No figures were available for Canadian dogs.

Stem cell therapies are not new to veterinary medicine. They have been around for about a decade, if not necessarily at the street level, according to Saanich veterinarian Geoff Gaunt.

Human patients, however, are still waiting for their use in treating arthritis.

Stem cell therapies for arthritis -- as promising as they appear -- are only in the preliminary research stage, according to Victoria orthopedic surgeon Colin Landells. Human medicine demands more extensive testing of drugs and procedures than does veterinary medicine.

Often viewed as a cure-all, stem cell therapy "may not be the panacea that people hope" for veterinary medicine, Gaunt warns.

Booth was guarded about the process new this year to Canada, but available in the U.S. since last year. She would have preferred it had been in use longer to gauge its effectiveness.

"I researched it before I agreed to do it," she says.

Her concern was primarily the efficacy of a treatment costing roughly $2,000 to $2,500 US, atop the local veterinarian's bill. As well, Booth wanted to know of potential side-effects.

"My first [criterion] was finding someone other than the company that says it works," she says.

Booth posted her questions on a veterinary information network. The results were encouraging, if not conclusive.

"It's difficult to be 100 per cent convinced," says Nick Shaw, a Central Saanich veterinarian familiar with the procedure.

"They do have some evidence to support it," he says.

Draibye understood the procedure might be something of "a lottery" for Micki. Roughly 70 per cent of dogs show improvement as Micki has, she says. The company puts the percentage somewhat higher.

As for those treated dogs who show no improvement? "You've spent your money for nothing," Draibye says.

Micki stayed a month recuperating with Draibye's family in Sooke before returning to Vancouver. The dog's exuberant personality proved a challenge. She craved more outdoor activity than her initial controlled five-minute walks allowed.

When Micki runs, there's still a slight hitch to one back leg, not noticeable at the walk or trot. Otherwise, the 11-year-old dog runs and plays much as she once did. This fall, Booth will inject more of Micki's stem cells, now "banked" in California, to further rejuvenate the joints.

However, Micki's vet bill was over $7,000, as it involved more than just the stem cell therapy. It included ligament surgery by a Victoria specialist plus the presence of a Vancouver anesthetist, which Draibye wanted to lessen any risk from the anesthetic with Micki's advancing years.

Booth is one of a handful of veterinarians in the province -- the website lists 28 in Canada -- accredited by Vet-Stem to do its procedure. Still, it isn't a therapy Booth envisions recommending to every owner with an arthritic dog. She just can't see it ever being relatively inexpensive for owners.

Cost seems no deterrent for Draibye when it involves Micki's quality of life.

"It's a lot of money, but she's a lot of dog," the 49-year-old lawyer says.

"I am not wealthy, but I can afford it."

Draibye has had Micki since she was a pup. She's her first dog.

Draibye doesn't consider it a waste of money to spend on an aging dog.

"Everybody adores their dog. I don't think they would give it a second thought," she says.

She finds other dog owners more than empathize with her: "They want to know if it would work for their dog."

Nor does their interest stop at just their dogs.

"They're wondering about their own joints," she says.

jgibson@tc.canwest.com

© Copyright (c) Canwest News Service

locksflooring

01/02/10 7:27 AM

#16141 RE: longhorn2745 #16130

US Veteran Brain Injury News

Will stem-cell research help U.S. wounded?

By Peter J. Bryant

More than 12,000 soldiers have been seriously wounded in the Iraq war since it began in 2003. Because of improvements in body armor since the Vietnam War, more soldiers in Iraq can survive bombings and sniper attacks, but this leaves a greater fraction of survivors with gruesome damage to the head, arms and legs caused by blast and shrapnel wounds.

Soldiers who would have died in previous wars are coming home with traumatic brain injury or as amputees. The military does not break down the statistics by type of wound, but according to Col. William Doukas, chairman of the Department of Orthopedics and Rehabilitation at Walter Reed Army Medical Center in Washington, "it is mostly legs." Bullets and shrapnel embedded in the brain are another common type of injury, and the metal is often left in place because removing it can do more damage than the injury itself.

Human limbs, brains and spinal cords are capable of only very limited repair following traumatic injury, so a lifetime of disability faces many of the victims. But many scientists are hopeful that with enough research, we will be able to harness the abilities of embryonic stem cells to form all of the cell types in the body, so that even whole limbs might be regenerated just as they are in a salamander, and neurons could be replaced and reconnected with each other and the organs they control.

Although the prospect of complete regeneration may seem far-fetched, recent discoveries show that stem cells may have beneficial effects even if they can't yet be used to replace lost body parts. After a traumatic injury to the central nervous system, many neurons survive the immediate injury but are then lost as a result of inflammation and loss of the myelin sheath that surrounds the axon and provides it with protection and electrical insulation.

Drs. Hans Keirstead and Oswald Steward, of the University of California at Irvine, have now shown that some of this secondary damage in the spinal cord can be prevented in animal models by treatment with specialized cells derived from human embryonic stem cells. Videos clearly show how rats retain much more mobility following spinal cord injury if they are given stem-cell therapy soon after the injury. The new results suggest that therapy with embryonic stem cells could reduce the amount of damage following traumatic injury to the central nervous system in humans, but the procedure must be more thoroughly tested on animals before it can be safely used on human patients.

Unfortunately, many of our best biologists, who could be working to make such therapies available, are hampered by Bush administration policies that do not allow federal funds to be used to generate new embryonic stem-cell lines or to work on any lines that have been generated since President Bush established the restrictions, based, as we now know, on his religious beliefs, in August 2001. Some scientists are finding ways to continue their embryonic stem-cell work with funding from private companies, while others plan to take advantage of funds freed up by the states, especially California, to compensate for the lack of federal funds.

Other nations with more liberal stem-cell policies are forging ahead and making the discoveries we need. Last month that was clearly happening: Scientists in Korea announced that they had solved the crucial problem of replacing the genes of stem cells with those of a potential patient, so the stem-cell products will not be rejected by the patient's immune system. Scientists all over the world had been eagerly anticipating that discovery, which removes a major scientific roadblock to cell-based therapy.

The United States has the most powerful federally funded health-research program in the world. As Bush indicated (as in announcing his decision to restrict federal support for research on embryonic stem cells), "Federal dollars help attract the best and brightest scientists. They ensure new discoveries are widely shared at the largest number of research facilities and that the research is directed toward the greatest public good. ... The United States has a long and proud record of leading the world toward advances in science and medicine that improve human life. And the United States has a long and proud record of upholding the highest standards of ethics as we expand the limits of science and knowledge."

Clearly, without the federal funding restrictions, the U.S. scientific community could be forging ahead to develop cellular therapies using embryonic stem cells. In anticipating that stem-cell research could lead to a society that creates human beings as a convenient source of spare body parts, Bush said, "I worry about a culture that devalues life." Many of us see a painful irony in that statement coming from a president who sent those 12,000 soldiers and many others to the battlefield in the first place.

In devoting their careers to stem-cell research and to developing therapies without the help of federal funds, scientists are not devaluing life but are recognizing the value of existing human lives and the potential of embryonic stem cells to transform the way that we treat not only battlefield injuries, but a host of other medical problems and genetic diseases as well. Unfortunately, unless the administration comes to its senses, those treatments may never be available to the maimed veterans in VA hospitals.

Peter Bryant is a professor of developmental and cell biology at UC Irvine (pjbryant@uci.edu).


seanman

01/02/10 10:44 AM

#16149 RE: longhorn2745 #16130

Working towards growing back
limbs and such would be nice.